1. De Paz D, Kao HK, Huang Y, Chang KP. Prognostic stratification of patients with advanced oral cavity squamous cell carcinoma. Curr Oncol Rep. 2017;19:65.

https://doi.org/10.1007/s11912-017-0624-3

PMid:28799122 

2. Bosetti C, Carioli G, Santucci C, Bertuccio P, Gallus S, Garavello W, et al. Global trends in oral and pharyngeal cancer incidence and mortality. Int J Cancer. 2020;147:1040-104.

https://doi.org/10.1002/ijc.32871

PMid:31953840 

3. Faria SO, Nascimento MCD, Kulcsar MAV. Malignant neoplasms of the oral cavity and oropharynx treated in Brazil: what do hospital cancer records reveal?. Braz J Otorhinolaryngol. 2020;S1808-8694:30089-6.

https://doi.org/10.1016/j.bjorl.2020.05.019

PMid:32682819 

4. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.

https://doi.org/10.3322/caac.21492

PMid:30207593 

5. Sasahira T, Kirita T. Hallmarks of Cancer-Related Newly Prognostic Factors of Oral Squamous Cell Carcinoma. Int J Mol Sci. 2018;19:2413.

https://doi.org/10.3390/ijms19082413

PMid:30115834 PMCid:PMC6121568

6. Jehn P, Dittmann J, Zimmerer R, Stier R, Jehn M, Gellrich NC, et al. Survival rates according to tumour location in patients with surgically treated oral and oropharyngeal squamous cell carcinoma. Anticancer Res. 2019;39:2527-33.

https://doi.org/10.21873/anticanres.13374

PMid:31092449 

7. Listl S, Jansen L, Stenzinger A, Freier K, Emrich K, Holleczeket B, et al. Survival of patients with oral cavity cancer in Germany. PLoS One. 2013;8:e53415.

https://doi.org/10.1371/journal.pone.0053415

PMid:23349710 PMCid:PMC3548847

8. Brandwein-Gensler M, Smith RV. Prognostic indicators in head and neck oncology including the new 7th edition of the AJCC staging system. Head Neck Pathol. 2010;4:53-61.

https://doi.org/10.1007/s12105-010-0161-y

PMid:20237990 PMCid:PMC2825522

9. Moro JS, Maroneze MC, Ardenghi TM, Barin LM, Danesi CC. Oral and oropharyngeal cancer: epidemiology and survival analysis. Einstein (Sao Paulo). 2018;16:1-5.

https://doi.org/10.1590/s1679-45082018ao4248

PMid:29898090 PMCid:PMC5995547

10. Frare JC, Sawazaki-Calone I, Ayroza-Rangel AL, Bueno AG, Morais CF, Nagai HM, et al. Histopathological grading systems analysis of oral squamous cell carcinomas of young patients. Med Oral Patol Oral Cir Bucal. 2016;21:e285-98.

https://doi.org/10.4317/medoral.20953

PMid:26946200 PMCid:PMC4867201

11. Cariati P, Cabello-Serrano A, Perez-de Perceval-Tara M, Monsalve-Iglesias F, Martínez-Lara I. Oral and oropharyngeal squamous cell carcinoma in young adults: A retrospective study in Granada University Hospital. Med Oral Patol Oral Cir Bucal. 2017;22:e679-85.

https://doi.org/10.4317/medoral.21755

PMid:29053649 PMCid:PMC5813985

12. Soudry E, Preis M, Hod R, Hamzany Y, Hadar T, Bahar G et al. Squamous cell carcinoma of the oral tongue in patients younger than 30 years: clinicopathologic features and outcome. Clin Otolaryngol. 2010;35:307-12.

https://doi.org/10.1111/j.1749-4486.2010.02164.x

PMid:20738340 

13. Santos‐Silva AR, Ribeiro ACP, Soubhia AMP, Miyahara GI, Carlos R, Speight PM, et al. High incidences of DNA ploidy abnormalities in tongue squamous cell carcinoma of young patients: an international collaborative study. Histopathology. 2011;58:1127-35.

https://doi.org/10.1111/j.1365-2559.2011.03863.x

PMid:21707713 

14. Hilly O, Shkedy Y, Hod R, Soudry E, Mizrachi A, Hamzany Y, et al. Carcinoma of the oral tongue in patients younger than 30 years: comparison with patients older than 60 years. Oral Oncol. 2013;49:987-90.

https://doi.org/10.1016/j.oraloncology.2013.07.005

PMid:23927849 

15. Tomo S, Neto SC, Collado FU, Sundefeld ML, Bernabé DG, Biasoli ÉR, et al. Head and neck squamous cell carcinoma in young patients: a 26-year clinicopathologic retrospective study in a Brazilian specialized center. Med Oral Patol Oral Cir Bucal. 2020;25:e416-24.

https://doi.org/10.4317/medoral.23461

PMid:32134900 PMCid:PMC7211379

16. Asio J, Kamulegeya A, Banura C. Survival and associated factors among patients with oral squamous cell carcinoma (OSCC) in Mulago hospital, Kampala, Uganda. Cancers Head Neck. 2018;3:9.

https://doi.org/10.1186/s41199-018-0036-6

PMid:31093362 PMCid:PMC6460549

17. Katna R, Kalyani N, Agarwal S, Singh S, Deshpande A, Bhosale B. Impact of comorbidities on perioperative outcomes for carcinoma of oral cavity. Ann R Coll Surg Engl. 2019;00:1-4.

PMid:31841025

18. De Santis S, Spinosi MC, Cambi J, Bengala C, Boccuzzi S. Oropharyngeal squamous cell carcinoma and HPV. Systematic review on overall management. J Stomatol Oral Maxillofac Surg. 2017;118:103-108.

https://doi.org/10.1016/j.jormas.2017.02.004

PMid:28345518 

19. Agarwal AK, Sethi A, Sareen D, Dhingra S. Treatment delay in oral and oropharyngeal cancer in our population: the role of socio-economic factors and health-seeking behaviour. Indian J Otolaryngol Head Neck Surg. 2011;63:145-50.

https://doi.org/10.1007/s12070-011-0134-9

PMid:22468251 PMCid:PMC3102173

20. Le Campiom ACOV, Ribeiro CMB, Luiz RR, Silva Júnior FF, Barros HCS, Santos KCB, et al. Low Survival Rates of Oral and Oropharyngeal Squamous Cell Carcinoma. Int J Dent. 2017;2017:58154931.

https://doi.org/10.1155/2017/5815493

PMid:28638410 PMCid:PMC5468590

21. Ghani WMN, Ramanathan A, Prime SS, Yang YH, Razak IA, Rahman ZAA, et al. Survival of oral cancer patients in different ethnicities. Cancer Invest. 2019;37:275-87.

https://doi.org/10.1080/07357907.2019.1635614

PMid:31307249 

22. Antunes JLF, Toporcov TN, Biazevic MGH, Boing AF, Bastos JL. Gender and racial inequalities in trends of oral cancer mortality in Sao Paulo, Brazil. Rev Saude Publica. 2013;47:470-478.

https://doi.org/10.1590/S0034-8910.2013047003724

PMid:24346559 

23. Osazuwa-Peters N, Massa ST, Christopher KM, Walker RJ, Varvares MA. Race and sex disparities in long‑term survival of oral and oropharyngeal cancer in the United States. J Cancer Res Clin Oncol. 2016;142:521-28.

https://doi.org/10.1007/s00432-015-2061-8

PMid:26507889 

24. Megwalu UC, Ma Y. Racial disparities in oropharyngeal cancer stage at diagnosis. Anticancer Res. 2017;37:835-40.

https://doi.org/10.21873/anticanres.11386

PMid:28179339 

25. Lifsics A, Rate E, Ivanova A, Tars J, Murovska M, Groma V. Survival analysis of oropharyngeal squamous cell carcinoma patients linked to histopathology, disease stage, tumor stage, risk factors, and received therapy. Exp Oncol. 2020;42:51-9.

https://doi.org/10.32471/exp-oncology.2312-8852.vol-42-no-1.14147

PMid:32231193 

26. Coca-Pelaz A, Takes RP, Hutcheson K, Saba NF, Haigentz M, Bradford CR, et al. Head and neck cancer: a review of the impact of treatment delay on outcome. Adv Ther. 2018;35:153-60.

https://doi.org/10.1007/s12325-018-0663-7

PMid:29396681 

27. Cunha AR, Prass TS, Hugo FN. Mortality from oral and oropharyngeal cancer in Brazil: impact of the National Oral Health Policy. Cad Saude Publica. 2019;35:e00014319.

https://doi.org/10.1590/0102-311x00014319

PMid:31800779 

28. Noro LRA, Landim JR, Martins MCA, Lima YCP. The challenge of the approach to oral cancer in primary health care. Cien Saude Colet. 2017;22:1579-87.

https://doi.org/10.1590/1413-81232017225.12402015

PMid:28538928 

29. Ong TK, Murphy C, Smith AB, Kanatasa AN, Mitchell DA. Survival after surgery for oral cancer: a 30-year experience. Br J Oral Maxillofac Surg. 2017;55:911-916.

https://doi.org/10.1016/j.bjoms.2017.08.362

PMid:28918183 

30. Stordeur S, Schillemans V, Savoye I, Vanschoenbeek K, Leroy R, Macq G, et al. Comorbidity in head and neck cancer: Is it associated with therapeutic delay, post-treatment mortality and survival in a population-based study?. Oral Oncol. 2020;102:104561.

https://doi.org/10.1016/j.oraloncology.2019.104561

PMid:31918175